Skip to page content

Tomas Philipson — Publications

Quantifying the Value of Personalized Medicines: Evidence from COX-2 Inhibitors

2013
The Value of Diagnostic Testing in Personalized Medicine

2013
An Analysis of Whether Higher Health Care Spending in the United States Versus Europe Is 'Worth It' in the Case of Cancer

2012
How Cancer Patients Value Hope and the Implications for Cost-Effectiveness Assessments of High-Cost Cancer Therapies

2012
The Large Social Value Resulting from Use of Statins Warrants Steps to Improve Adherence and Broaden Treatment

2012
The Benefits from Giving Makers of Conventional 'Small Molecule' Drugs Longer Exclusivity Over Clinical Trial Data

2011
An Economic Evaluation of the War on Cancer

2010
Valuing Health Technologies at NICE: Recommendations for Improved Incorporation of Treatment Value in HTA

2010
An Economic Evaluation of the War on Cancer

2009
The Effects of Product Liability Exemption in the Presence of the FDA

2009
Drug Licenses: A New Model for Pharmaceutical Pricing

2008
Intellectual Property and Marketing

2006
Welfare-Enhancing Technological Change and the Growth of Obesity

2005
Welfare-Enhancing Technological Change and the Growth of Obesity

2005
The Rise in Old Age Longevity and the Market for Long-Term Care

2002
Technological Change and the Growth of Obesity: A Theoretical and Empirical Examination

2002
An Empirical Examination of the Implications of Assortative Matching on the Incidence of HIV

1996